Phase I Clinical Trial in Healthy Male Volunteers

Phase I Randomized,Double-Blind,Placebo-controlled Trial in Healthy Male Voluteers To Examine the Safety,Tolerability,and Pharmacokinetics of HMPL-011 After A Single Dose.

Overview

ClinicalTrials.gov ID: NCT03860532
Lead Sponsor: Hutchison Medipharma LimitedINDUSTRY
Brief Summary: This is a Phase I Randomized,Double-Blind,Placebo-controlled Trial in Healthy Male Voluteers To Examine the Safety,Tolerability,and Pharmacokinetics of HMPL-011 After A Single Dose.
Study Type: Interventional

Phase

Phase 1

Enrollment

24Actual

Conditions

Inflammatory Bowel Diseases

Interventions

Drug: HMPL-011 tabletsDrug: HMPL-011 capsules

Organization Study ID

2009-011-00AU1

Similar Studies

Status

Overall Status: Completed
Start Date: Sep 2011
Primary Completion Date: Dec 2011Actual
Completion Date: Dec 2011Actual

Study Record Dates

First Submitted: Mar 15, 2012
First Submitted that Met QC Criteria: Feb 28, 2019
First Posted: Mar 4, 2019Actual
Last Update Submitted that Met QC Criteria: Mar 3, 2019
Last Update Posted: Mar 5, 2019Actual
Last Verified: Mar 2019

NCT03597971Terminated

HMPL004-6599 Phase I Dose-escalating Study

NCT02631642Completed

A Study of HMPL-689 in Healthy Volunteers

NCT02105129Completed

A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523

NCT05536440Completed

A Study to Learn About Study Medicine Called PF-07261271 in Healthy People

NCT00655733Completed

Phase II Study of HMPL-004 in Subjects With Crohn's Disease

NCT02603185Unknown status

PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers